Dosimetric Impact of Image-Guided Radiotherapy in Liver Stereotactic Radiotherapy.
In the absence of volumetric image-guided radiotherapy (IGRT) with or without intravenous contrast, IGRT with two-dimensional (2D) imaging can improve the accuracy and precision of radiation delivery by correcting the largest sources of geometric uncertainty, facilitating the delivery of higher doses to the tumor and/or reduced doses to normal tissues. The purpose of this work was to estimate dosimetric impact of 2D IGRT for patients undergoing breath hold liver stereotactic body radiotherapy (SBRT). Offline residual offsets were determined using orthogonal image pairs acquired with patients positioned with external setup marks (non-IGRT) and following IGRT and repositioning (IGRT) for 30 patients treated with 6-fraction liver SBRT. The diaphragm was used as a surrogate for the liver for craniocaudal positioning, and the vertebral bodies for anterioposterior and right-left positioning, with a 3-mm threshold. The planned dose distributions were shifted by the measured IGRT and non-IGRT offsets. Total doses to target volumes and organs at risk (OAR) were calculated and compared to the prescribed plans. A total of 643 images (416-MV electronic portal images; 227 kV cone beam computed tomography projection images) were evaluated. Residual non-IGRT offsets frequently exceeded 3 mm (72%), resulting in clinically significant variations from the prescribed minimum planning target volume dose (mean change -6.5 Gy; P =.0150). The population mean reductions in minimum gross tumor volume doses (standard deviation (σ) to 0.5 mL with were 7.2 Gy (6.3) and 4.7 Gy (6.1) for non-IGRT and IGRT, respectively. The mean population increase in maximum OAR dose (to 0.5 mL) was largest for bowel (2.7 Gy, σ = 5.5 Gy) for non-IGRT. IGRT significantly improves concordance of delivered doses with planned doses for liver target volumes and OARs.